Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies

OBJECTIVES: In patients with systemic autoimmune rheumatic disorders (SARDs), vaccination with SARS-CoV-2 mRNA vaccines has been proposed. The aim of this study is to evaluate the immune response elicited by vaccination with mRNA vaccine, testing IgM, IgA and IgG antibodies to SARS-CoV-2 receptor-bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Chiara, Pratesi, Federico, Talarico, Rosaria, Cardelli, Chiara, Caruso, Teresita, Di Cianni, Federica, Laurino, Elenia, Italiano, Nazzareno, Moretti, Michele, Manca, Maria Laura, Migliorini, Paola, Mosca, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655339/
https://www.ncbi.nlm.nih.gov/pubmed/34880126
http://dx.doi.org/10.1136/rmdopen-2021-001914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655339/
https://www.ncbi.nlm.nih.gov/pubmed/34880126
http://dx.doi.org/10.1136/rmdopen-2021-001914

Ejemplares similares